Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
Tags
Data and Resources
To access the resources you must log in
This item has no data
Item URL
http://data.d4science.org/ctlg/RISIS2OpenData/dedup_wf_001--d8b1e9889d255f49d6d9463ee4d9723c |
|
Identity
Access Modality
Field | Value |
---|---|
Access Right | Open Access |
Attribution
Field | Value |
---|---|
Author | Ong The Due , 0000-0001-5787-4145 |
Publishing
Field | Value |
---|---|
Collected From | PubMed Central; ORCID; UnpayWall; Datacite; figshare; Crossref; Microsoft Academic Graph |
Hosted By | Europe PubMed Central; figshare; Expert Review of Clinical Pharmacology |
Journal | Expert Review of Clinical Pharmacology, 12, null |
Publication Date | 2019-07-09 |
Publisher | Informa UK Limited |
Additional Info
Field | Value |
---|---|
Language | Undetermined |
Resource Type | Other literature type; Article |
keyword | keywords.General Pharmacology, Toxicology and Pharmaceutics |
keyword | FOS: Computer and information sciences |
system:type | publication |
Management Info
Field | Value |
---|---|
Source | https://science-innovation-policy.openaire.eu/search/publication?articleId=dedup_wf_001::d8b1e9889d255f49d6d9463ee4d9723c |
Author | jsonws_user |
Last Updated | 27 December 2020, 02:03 (CET) |
Created | 27 December 2020, 02:03 (CET) |